Clinical Trials
10
Active:0
Completed:9
Trial Phases
2 Phases
Phase 4:7
Not Applicable:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (8 trials with phase data)• Click on a phase to view related trials
Phase 4
7 (87.5%)Not Applicable
1 (12.5%)Efficacy of Ferric Carboxymaltose Versus Iron Sucrose in Non-dialysis Dependent Chronic Kidney Disease Patients
Not Applicable
Recruiting
- Conditions
- Iron Deficiency Anemia Associated With Non-Dialysis Dependent Chronic Kidney Disease
- Interventions
- Drug: Ferric Carboxymaltose (FCM)
- First Posted Date
- 2025-05-29
- Last Posted Date
- 2025-08-12
- Lead Sponsor
- Sindh Institute of Urology and Transplantation
- Target Recruit Count
- 128
- Registration Number
- NCT06994065
- Locations
- 🇵🇰
Sindh Institute of Urology and Transplantaion, Karachi, Sindh, Pakistan
Permanent Celiac Plexus Block: Comparison of Pain Score in Unilateral and Bilateral Posterior Percutaneous Approach
Phase 4
Completed
- Conditions
- Abdominal CancerCancer PainCancer of Pancreas
- Interventions
- Drug: Unilateral Neurolytic Celiac Plexus Block with Absolute AlcoholDrug: Bilateral Neurolytic Celiac Plexus Block with Absolute Alcohol
- First Posted Date
- 2024-03-19
- Last Posted Date
- 2024-03-19
- Lead Sponsor
- Sindh Institute of Urology and Transplantation
- Target Recruit Count
- 30
- Registration Number
- NCT06316908
- Locations
- 🇵🇰
Sindh Institute of Urology and Transplantation, Karachi, Sindh, Pakistan
Dexmedetomidine Versus Ketofol for Moderate Sedation in Endoscopic Retrograde Cholangiopancreatography
- First Posted Date
- 2024-01-18
- Last Posted Date
- 2024-01-18
- Lead Sponsor
- Sindh Institute of Urology and Transplantation
- Target Recruit Count
- 62
- Registration Number
- NCT06212401
- Locations
- 🇵🇰
Sindh Institute of Urology and Transplantation, Karachi, Sindh, Pakistan
Comparison Between Sevoflurane and Propofol for Maintenance of Sedation During ERCP
Phase 4
Completed
- Conditions
- Sedation Complication
- Interventions
- First Posted Date
- 2023-08-18
- Last Posted Date
- 2023-08-18
- Lead Sponsor
- Sindh Institute of Urology and Transplantation
- Target Recruit Count
- 86
- Registration Number
- NCT05996588
- Locations
- 🇵🇰
Syed Muhammad Abbas, Karachi, Sindh, Pakistan
Effects of Intrathecal Dexmedetomidine as an Adjuvant to Low Dose Hyperbaric 0.5% Bupivacaine
Phase 4
Completed
- Conditions
- Post Operative Pain
- Interventions
- Drug: Bupivacain 0.5%
- First Posted Date
- 2023-08-16
- Last Posted Date
- 2023-10-31
- Lead Sponsor
- Sindh Institute of Urology and Transplantation
- Target Recruit Count
- 108
- Registration Number
- NCT05993975
- Locations
- 🇵🇰
Syed Muhammad Abbas, Karachi, Sindh, Pakistan
- Prev
- 1
- 2
- Next
News
No news found